Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past …
vaccines, focusing on vaccine coverage and efficacy. In addition, pan-gender vaccination …

… The safety profile of both vaccines was assessed extensively in randomised controlled …
regarding the safety of HPV vaccines. In summary, both vaccines are associated with relatively …

… Vaccination Impact Study Group. Population-level impact and herd effects following the
introduction of human papillomavirus vaccination … human papillomavirus prophylactic vaccines. …

… of human papillomavirus (HPV). Two recently developed prophylactic cervical cancer vaccines,
… To increase vaccination coverage, national programmes in some countries have also …

… Identification of human papillomavirus (… vaccines to control HPV-associated malignancies.
Excitement has been generated by the commercialization of two preventive L1-based vaccines…

… human papillomavirus (HPV) vaccines are available that are highly efficacious against persistent
vaccine-… in females and males has been documented only for the quadrivalent vaccine …

… HPV vaccines have been proven notably efficacious in clinical trials, the effectiveness of these
vaccines at … While research on the vaccines’ effects on these HPV clinical outcomes in the …

… , two different human papillomavirus virus (HPV) vaccines were licensed for use: a
quadrivalent (qHPVv) and a bivalent (bHPVv) vaccine. Since 2008, HPV vaccination programmes …

… Human papillomavirus (HPV) infection causes virtually all … This Review examines prophylactic
HPV subunit vaccines based on … are developing commercial versions of the vaccine. Both …

… -like particle vaccine against human papillomavirus types 16 … particle vaccine against
infection with human papillomavirus … of human papillomavirus 16/18 L1 viruslike particle vaccine …